Read More Pharma Industry News Kodiak Sciences completes enrollment for KSI-301 safety study in retinal disease Kodiak Sciences, a California-based biotechnology company, has recently completed patient enrollment for a phase 1 safety and tolerability… bypharmanewsdailySeptember 2, 2018
